Read + Share
Amedeo Smart
Independent Medical Education
Li MY, Chong LC, Duns G, Lytle A, et al. TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic target in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A 2024;121:e2320421121.PMID: 38662551
Email
LinkedIn
Facebook
Twitter
Privacy Policy